Supplemental material
Leukemia & Lymphoma
Volume 62, 2021 - Issue 2
Letters to the Editor
Dexrazoxane enhances efficacy of all-trans retinoic acid in acute myeloid leukemia patient blast cells and cell lines
Eric J. Norrisa Department of Cancer Pharmacology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA
https://orcid.org/0000-0002-9204-5235
https://orcid.org/0000-0002-9204-5235, , , , Wendell D. Jonesc EA Genomics, Division of Q Solutions, Morrisville, NC, USAhttps://orcid.org/0000-0002-9676-5387
https://orcid.org/0000-0002-9676-5387, Jaroslaw P. Maciejewskid Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USAhttps://orcid.org/0000-0002-6837-4346
https://orcid.org/0000-0002-6837-4346, Ram N. Ganapathia Department of Cancer Pharmacology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USAhttps://orcid.org/0000-0001-8615-0170
https://orcid.org/0000-0001-8615-0170 & Mahrukh K. Ganapathia Department of Cancer Pharmacology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USACorrespondence[email protected] [email protected] [email protected]
https://orcid.org/0000-0001-7312-8150
https://orcid.org/0000-0001-7312-8150 show all